These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19737236)

  • 1. Intravenous immunoglobulin preparations have no direct effect on B cell proliferation and immunoglobulin production.
    Heidt S; Roelen DL; Eijsink C; Eikmans M; Claas FH; Mulder A
    Clin Exp Immunol; 2009 Oct; 158(1):99-105. PubMed ID: 19737236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous IgG (IVIG) and subcutaneous IgG (SCIG) preparations have comparable inhibitory effect on T cell activation, which is not dependent on IgG sialylation, monocytes or B cells.
    Issekutz AC; Rowter D; Miescher S; Käsermann F
    Clin Immunol; 2015 Oct; 160(2):123-32. PubMed ID: 25982320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro inhibition by intravenous immunoglobulin of human T cell-dependent B cell differentiation induced by staphylococcal superantigens.
    Stohl W; Elliot JE
    Clin Immunol Immunopathol; 1996 May; 79(2):122-33. PubMed ID: 8620618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous immunoglobulin G-mediated inhibition of T-cell proliferation reflects an endogenous mechanism by which IgG modulates T-cell activation.
    MacMillan HF; Lee T; Issekutz AC
    Clin Immunol; 2009 Aug; 132(2):222-33. PubMed ID: 19447680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous immunoglobulin inhibits IgE production in human B lymphocytes.
    Sigman K; Ghibu F; Sommerville W; Toledano BJ; Bastein Y; Cameron L; Hamid QA; Mazer B
    J Allergy Clin Immunol; 1998 Sep; 102(3):421-7. PubMed ID: 9768583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of immunoglobulin production in vitro by IgG and F(ab')2 fragments, but not by the Fc portion.
    Klaesson S; Tammik L; Markling L; Lundkvist I; Ringdén O
    Scand J Immunol; 1996 May; 43(5):574-82. PubMed ID: 8633217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous immunoglobulins suppress immunoglobulin productions by suppressing Ca(2+)-dependent signal transduction through Fc gamma receptors in B lymphocytes.
    Kondo N; Kasahara K; Kameyama T; Suzuki Y; Shimozawa N; Tomatsu S; Nakashima Y; Hori T; Yamagishi A; Ogawa T
    Scand J Immunol; 1994 Jul; 40(1):37-42. PubMed ID: 8029641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro effects of everolimus and intravenous immunoglobulin on cell proliferation and apoptosis induction in the mixed lymphocyte reaction.
    Amet N; Gacad M; Petrosyan A; Pao A; Jordan SC; Toyoda M
    Transpl Immunol; 2010 Aug; 23(4):170-3. PubMed ID: 20609387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycophenolic acid and intravenous immunoglobulin exert an additive effect on cell proliferation and apoptosis in the mixed lymphocyte reaction.
    Sharma KG; Radha R; Pao A; Amet N; Baden L; Jordan SC; Toyoda M
    Transpl Immunol; 2010 Jul; 23(3):117-20. PubMed ID: 20450974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulatory effects of different intravenous immunoglobulin preparations in chronic lymphocytic leukemia.
    Colado A; Elías EE; Sarapura Martínez VJ; Cordini G; Morande P; Bezares F; Giordano M; Gamberale R; Borge M
    Sci Rep; 2021 Jun; 11(1):12926. PubMed ID: 34155276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of IgE production in vitro by intact and fragmented intravenous immunoglobulin.
    Zhuang Q; Mazer B
    J Allergy Clin Immunol; 2001 Aug; 108(2):229-34. PubMed ID: 11496239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous immunoglobulin induces proliferation and immunoglobulin synthesis from B cells of patients with common variable immunodeficiency: a mechanism underlying the beneficial effect of IVIg in primary immunodeficiencies.
    Bayry J; Fournier EM; Maddur MS; Vani J; Wootla B; Sibéril S; Dimitrov JD; Lacroix-Desmazes S; Berdah M; Crabol Y; Oksenhendler E; Lévy Y; Mouthon L; Sautès-Fridman C; Hermine O; Kaveri SV
    J Autoimmun; 2011 Feb; 36(1):9-15. PubMed ID: 20970960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA Class Ia and Ib Polyreactive Anti-HLA-E IgG2a Monoclonal Antibodies (TFL-006 and TFL-007) Suppress Anti-HLA IgG Production by CD19+ B Cells and Proliferation of CD4+ T Cells While Upregulating Tregs.
    Ravindranath MH
    J Immunol Res; 2017; 2017():3475926. PubMed ID: 28634589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of IgA production by lymphocytes induced by diphenylhydantoin.
    Kondo N; Takao A; Tomatsu S; Shimozawa N; Suzuki Y; Ogawa T; Iwata H; Orii T
    J Investig Allergol Clin Immunol; 1994; 4(5):255-7. PubMed ID: 7874323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of human intravenous immunoglobulin on canine monocytes and lymphocytes.
    Reagan WJ; Scott-Moncrieff C; Christian J; Snyder P; Kelly K; Glickman L
    Am J Vet Res; 1998 Dec; 59(12):1568-74. PubMed ID: 9858408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-4 suppresses immunoglobulin production by peripheral blood lymphocytes of patients with common variable immunodeficiency (CVI) induced by supernatants of T cell clones.
    Pastorelli G; Roncarolo MG; Touraine JL; Rousset F; Pene J; de Vries JE
    Clin Exp Immunol; 1989 Dec; 78(3):341-7. PubMed ID: 2575470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous immunoglobulin induces a functional silencing program similar to anergy in human B cells.
    Séïté JF; Goutsmedt C; Youinou P; Pers JO; Hillion S
    J Allergy Clin Immunol; 2014 Jan; 133(1):181-8.e1-9. PubMed ID: 24139609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered immunoglobulin A and M levels associated with changes in BAFF and APRIL after administration of intravenous immunoglobulin to treat Kawasaki disease.
    Doi M; Takeda T; Sakurai Y; Kato J; Hayashi T; Fukuda K; Takase T; Shima M
    J Investig Allergol Clin Immunol; 2010; 20(5):413-8. PubMed ID: 20945608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superior immunomodulatory effects of intravenous immunoglobulins on human T-cells and dendritic cells: comparison to calcineurin inhibitors.
    Tha-In T; Metselaar HJ; Tilanus HW; Boor PP; Mancham S; Kuipers EJ; de Man RA; Kwekkeboom J
    Transplantation; 2006 Jun; 81(12):1725-34. PubMed ID: 16794540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in the understanding of the mechanism of action of IVIg.
    Hartung HP
    J Neurol; 2008 Jul; 255 Suppl 3():3-6. PubMed ID: 18685919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.